Literature DB >> 216684

The chemistry and biology of thymosin. I. Isolation, characterization, and biological activities of thymosin alpha1 and polypeptide beta1 from calf thymus.

T L Low, G B Thurman, M McAdoo, J McClure, J L Rossio, P H Naylor, A L Goldstein.   

Abstract

A partially purified extract from thymus tissue termed thymosin Fraction 5 has been shown to reconstitute immunological deficiencies resulting from the lack of thymic function in several animal models, as well as humans with primary and secondary immunodeficiency diseases. Thymosin Fraction 5 consists of a family of polypeptides with molecular weights ranging from 1,000 to 15,000. Several of these polypeptides contribute individually to the biological activity of the parent compound. Two polypeptide components of thymosin Fraction 5, termed thymosin alpha1 and polypeptide beta1, have been characterized chemically and biologically. Thymosin alpha1 is a highly acidic molecule composed of 28 amino acid residues. This polypeptide has potent biological activity and has been found to be 10 to 1,000 times as active as thymosin Fraction 5 in one in vivo and several in vitro bioassay systems designed to measure differentiation and function of thymus-dependent lymphocytes (T cells). Polypeptide beta1, in contrast, is inactive in our bioassay systems, suggesting that it is not involved in thymic hormone action. Sequence analysis and homology studies have indicated that polypeptide beta1, although present in Fraction 5, does not contribute to the biological activity of thymosin Fraction 5.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 216684

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Quantitative analysis of thymosin alpha1 in human serum by LC-MS/MS.

Authors:  C W Tuthill; A Rudolph; Y Li; B Tan; T J Fitzgerald; S R Beck; Y X Li
Journal:  AAPS PharmSciTech       Date:  2000-05-14       Impact factor: 3.246

2.  Thymosin beta 4 (Fx peptide) is a potent regulator of actin polymerization in living cells.

Authors:  M C Sanders; A L Goldstein; Y L Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

3.  Localization of thymosin beta10 in breast cancer cells: relationship to actin cytoskeletal remodeling and cell motility.

Authors:  Aase Elisabeth Maelan; Trine Kring Rasmussen; Lars-Inge Larsson
Journal:  Histochem Cell Biol       Date:  2006-06-20       Impact factor: 4.304

Review 4.  Functional anatomy of the thymic microenvironment.

Authors:  M D Kendall
Journal:  J Anat       Date:  1991-08       Impact factor: 2.610

5.  Three-dimensional structure of ubiquitin at 2.8 A resolution.

Authors:  S Vijay-Kumar; C E Bugg; K D Wilkinson; W J Cook
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

6.  A rapid and systemic complete response to stereotactic body radiation therapy and pembrolizumab in a patient with metastatic renal cell carcinoma.

Authors:  Guozhu Xie; Di Gu; Lanfang Zhang; Shijun Chen; Dehua Wu
Journal:  Cancer Biol Ther       Date:  2017-06-30       Impact factor: 4.742

7.  Thymosins beta 8 and beta 9: two new peptides isolated from calf thymus homologous to thymosin beta 4.

Authors:  E Hannappel; S Davoust; B L Horecker
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

8.  Different thymosin Beta 4 immunoreactivity in foetal and adult gastrointestinal tract.

Authors:  Sonia Nemolato; Tiziana Cabras; Flaviana Cau; Mattia Umberto Fanari; Daniela Fanni; Barbara Manconi; Irene Messana; Massimo Castagnola; Gavino Faa
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

9.  Induction of terminal deoxynucleotidyl transferase and Lyt antigens with thymosin: identification of multiple subsets of prothymocytes in mouse bone marrow and spleen.

Authors:  I Goldschneider; A Ahmed; F J Bollum; A L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

10.  Prothymosin alpha in human blood.

Authors:  C Panneerselvam; A A Haritos; J Caldarella; B L Horecker
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.